Ophthalmic Devices - Northern Africa

  • Northern Africa
  • The Ophthalmic Devices market market in Northern Africa is anticipated to witness a significant boost in revenue, with projections indicating it will reach a staggering US$300.50m by the year 2024.
  • Furthermore, experts predict a steady annual growth rate of 6.81% (CAGR 2024-2029), leading to a substantial market volume of US$417.80m by 2029.
  • It is worth noting that, when compared globally, the United States is expected to generate the highest revenue, estimated to be US$14,000.00m in 2024.
  • The demand for ophthalmic devices in Northern Africa is rising due to the increasing prevalence of eye diseases in the region.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Northern Africa is experiencing significant growth and development, driven by various factors such as increasing customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Ophthalmic Devices market in Northern Africa are shifting towards more advanced and innovative eye care solutions. Customers are increasingly seeking devices that offer improved accuracy, precision, and comfort. This preference for advanced technology is driving the demand for products such as refractive surgery devices, diagnostic and monitoring devices, and surgical instruments. Additionally, there is a growing demand for contact lenses and spectacles, as customers look for fashionable and customizable options to correct their vision. Trends in the Ophthalmic Devices market in Northern Africa are also contributing to its development. One notable trend is the increasing adoption of telemedicine and remote monitoring solutions. This trend has been accelerated by the COVID-19 pandemic, as patients and healthcare providers seek alternative ways to access eye care services. Telemedicine allows for remote consultations, diagnosis, and monitoring, reducing the need for in-person visits and improving accessibility to eye care services, particularly in rural areas. Local special circumstances in Northern Africa also play a role in the development of the Ophthalmic Devices market. The region has a high prevalence of eye diseases and vision impairments, such as cataracts, glaucoma, and refractive errors. This creates a significant demand for ophthalmic devices and treatments. Additionally, Northern Africa has a growing elderly population, which is more prone to age-related eye conditions. This demographic trend further drives the demand for ophthalmic devices and services. Underlying macroeconomic factors also contribute to the growth of the Ophthalmic Devices market in Northern Africa. The region is experiencing economic growth, leading to an increase in disposable income and healthcare spending. As a result, more individuals are able to afford eye care services and devices. Furthermore, governments in the region are investing in healthcare infrastructure and implementing policies to improve access to eye care services, which further supports the growth of the market. In conclusion, the Ophthalmic Devices market in Northern Africa is developing rapidly due to increasing customer preferences for advanced eye care solutions, emerging trends such as telemedicine, local special circumstances including a high prevalence of eye diseases, and underlying macroeconomic factors such as economic growth and government investments in healthcare. These factors are driving the demand for ophthalmic devices and services, creating opportunities for market players in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)